Frantz Viral Therapeutics
PrivateLast Round
Joint Venture
Jun 1, 2015
Company Overview
Frantz Viral Therapeutics is a biotechnology company that develops non-surgical, topical treatments for HPV-induced conditions and cancers using artemisinin-related compounds.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frantz Viral Therapeutics Comparables
Compare Frantz Viral Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amplexd Therapeutics | 88% | |
| Antiva Biosciences | 84% | |
| Asieris Pharmaceuticals | 72% |
Frantz Viral Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Jun 1, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2015
Secured funding from Frantz Medical Group and Georgetown University.
Frantz Viral Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Frantz Viral Therapeutics's valuation, stock price, and market status.
Is Frantz Viral Therapeutics a public or private company?
Frantz Viral Therapeutics is a private company.
What is the current stock price of Frantz Viral Therapeutics?
Frantz Viral Therapeutics is a private company, so its shares have no public market price. Caplight tracks Frantz Viral Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Frantz Viral Therapeutics worth (valuation)?
Valuation information for Frantz Viral Therapeutics is not publicly available.
Can I buy Frantz Viral Therapeutics stock?
Frantz Viral Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Frantz Viral Therapeutics's last funding round?
Frantz Viral Therapeutics's most recent funding round was Joint Venture on June 1, 2015.
Who are the main investors in Frantz Viral Therapeutics?
Investor information for Frantz Viral Therapeutics is not publicly disclosed.
Will Frantz Viral Therapeutics IPO soon?
No public IPO plans have been announced for Frantz Viral Therapeutics.
How can I track Frantz Viral Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Frantz Viral Therapeutics's shares on secondary markets.